← Back to Clinical Trials
Recruiting NCT04923828
Chinese PICU Collaborative Network on Pathogens and Drug Resistance of Severe Infections
◆ AI Clinical Summary
Plain-language summary for patients
Trial Parameters
Condition Severe Infection
Sponsor Children's Hospital of Fudan University
Study Type OBSERVATIONAL
Phase N/A
Enrollment 2,000
Sex ALL
Min Age 1 Month
Max Age 16 Years
Start Date 2023-12-31
Completion 2026-12-31
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
To investigate PICUs in major cities in China by establishing a high-quality standardized clinical database of PICU inpatients Incidence, fatality rate, pathogen distribution, anti-infective treatment of community-acquired/nosocomial infections in inpatients.
Eligibility Criteria
Inclusion Criteria: * PICU patients with severe infection Exclusion Criteria: * Non-infected patient
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology